Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Eden Research Share Price
  4. Eden Research Share Regulatory News
  5. AIM Rule 17 Notification

Pin to quick picksEden Research Regulatory News (EDEN)

Eden Research Information

Share Price Information for Eden Research (EDEN)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.10
Ask:
3.20
Spread: 0.10 (3.226%)
Market Cap: £25.31m
EDEN Live PriceLast checked at - London Stock Exchange

Intraday Eden Research Share Chart

AIM Rule 17 Notification

24 Oct 2022 12:00

RNS Number : 8925D
Eden Research plc
24 October 2022
 

24 October 2022

 

Eden Research Plc

("Eden" or the "Company")

AIM Rule 17 Notification

Eden Research Plc (AIM: EDEN) the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces the following additional director disclosure provided pursuant to AIM Rule 17 and Schedule 2(g) of the AIM Rules.

Richard Horsman, Non-executive director of Eden, is Non-executive chairman of Toople Plc ("Toople"). On 21 October 2022, the Directors of Toople appointed an administrator to preserve value for creditors.

 

For further information contact:

 

Eden Research plc

www.edenresearch.com

Sean SmithAlex Abrey

 

 

01285 359 555

Cenkos Securities plc (Nominated advisor and broker)

Giles Balleny / Max Gould (corporate finance)Michael Johnson (sales)

 

 

020 7397 8900

Hawthorn Advisors (Financial PR)

Victoria AinsworthStephen Atkinson

 

eden@hawthornadvisors.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNUSARRUUURUAA
1234567
Date   Source Headline
5th Mar 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSEU Product Authorisation - Cedroz
15th Jan 20197:00 amRNSYear-end trading update
20th Dec 20187:00 amRNSSipcam exercises Option for distribution
5th Dec 20188:00 amRNSHolding(s) in Company
5th Dec 20188:00 amRNSHolding(s) in Company
30th Nov 20188:30 amRNSHolding(s) in Company
13th Nov 20187:00 amRNSEastman highly commended at Agrow Awards
15th Oct 20187:00 amRNSSipcam agreement for Australia and New Zealand
10th Oct 20189:00 amRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSApproval of TerpeneTech head-lice product
24th Sep 20187:00 amRNSHalf-year Report
13th Jul 201810:23 amRNSDirector/PDMR Shareholding
21st Jun 20184:44 pmRNSResult of AGM
21st Jun 20187:00 amRNSAGM Statement
19th Jun 20187:00 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSRegulatory Progress Update
30th May 20182:30 pmRNSPosting of Annual Report & Notice of AGM
10th May 20185:04 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSExercise of Options
20th Mar 20187:00 amRNSPreliminary results
11th Jan 20187:00 amRNSYear-end Trading Statement
12th Dec 20177:00 amRNSRegulatory Progress Update
29th Sep 201711:15 amRNSHalf-year Report - Replacement
29th Sep 20177:30 amRNSAdoption of New LTIP and Grant of Awards
29th Sep 20177:01 amRNSBoard Changes
29th Sep 20177:00 amRNSHalf-year Report
25th Sep 20177:00 amRNSApproval of MevaloneT in Portugal
1st Sep 20177:00 amRNSNotice of Results
30th Jun 20175:14 pmRNSHolding(s) in Company
30th Jun 201712:29 pmRNSResult of AGM
30th Jun 20177:43 amRNSAGM Statement
30th Jun 20177:39 amRNSCompletion of Placing & Subscription
30th Jun 20177:00 amRNSSipcam agreements, investment and proposed placing
29th Jun 20179:43 amRNSNew terms agreed with UMMS
5th Jun 20173:14 pmRNSPosting of Annual Report & Notice of AGM
22nd May 20177:00 amRNSFinal Results
11th May 20179:00 amRNSEden Research on BBC Radio 4's You & Yours
29th Mar 20177:00 amRNSExtension of patent protection in Greece
8th Mar 20172:40 pmRNSVoting Rights, Warrants and Options Outstanding
23rd Jan 20172:00 pmRNSPrice Monitoring Extension
23rd Jan 20177:00 amRNSFungicide product approved for sale in France
21st Dec 20167:01 amRNSTrading update
21st Dec 20167:00 amRNSEastman commercialisation agreement for nematicide
27th Sep 20167:00 amRNSHalf-year Report
28th Jun 201612:28 pmRNSResult of AGM
28th Jun 20167:00 amRNSAGM Statement
15th Jun 20167:00 amRNSLabel extensions for 3AEY in Spain and Greece
7th Jun 20167:00 amRNSPosting of Annual Report & Notice of AGM
26th May 20163:36 pmRNSDirector/PDMR Shareholding
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
JEDT
JPMorgan European Discovery Trust
LSE
0.61%
IMG
Imagination Technologies Group
LSE
0.00%
SIGT
SIGT.L
LSE
0.00%
RECI
Real Est.cred
LSE
-0.86%
OZ00
Citi Fun 26
LSE
0.00%
Trending
QHE
Quantum Helium
LSE
6.67%
GGP
Greatland Resources
LSE
-2.84%
OMI
Orosur Mining
LSE
0.81%
KEFI
Kefi Gold & Copper
LSE
-4.23%
PLE
Plethora Solutions Holdings Plc
LSE
0.00%